For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260114:nRSN9338Oa&default-theme=true
RNS Number : 9338O Goldman Sachs ETF ICAV 14 January 2026
Stock Exchange Announcement
For immediate release 14 January 2026
Goldman Sachs ETF ICAV
Terms not defined in this notice have the same meaning given to them in the ICAV's prospectus (the "Prospectus").
Re: Notice to Shareholders regarding closure of a sub-fund of Goldman Sachs ETF ICAV
Goldman Sachs ETF ICAV (the "ICAV") announces the closure of the Goldman Sachs
ActiveBeta Emerging Markets Equity UCITS ETF (ISIN: IE00BJ5CMD00), a sub-fund
of the ICAV, (the "Fund") with effect from 02 April 2026 (the "Effective
Date").
Procedure for closure of the Fund
On the primary market, if you do not redeem your Shares before the Effective
Date, your Shares will be redeemed at the applicable Net Asset Value per Share
less any associated Duties and Charges, in accordance with the terms of the
Prospectus.
For secondary market orders, the last day for trading on each Listing Stock 23 March 2026
Exchange on which the Shares are listed and traded will be:
For primary market orders, the last day on which applications for the creation
and redemption of Shares by Authorised Participants will be:
24 March 2026
Following the compulsorily redemption of all Shares on the Effective Date, the
redemption proceeds, calculated as of the Effective Date, will be remitted to
Shareholders within 10 Business Days.
Full details, including key dates and investor information, are available in
the comprehensive notice on the following webpage: Notice to Shareholders
regarding closure of sub-fund
(https://am.gs.com/public-assets/documents/78a7ebe1-f14a-11f0-8947-ad7f42f1a2be?view=true)
(https://www.yourcompanywebsite.com/etf-termination-details.docx) .
ENQUIRIES
Goldman Sachs Contact: Andy Moore
Email: andy.moore@gs.com (mailto:andy.moore@gs.com)
Phone: +44 20 7051 4001
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCGZGMMVDGGVZM
Copyright 2019 Regulatory News Service, all rights reserved